Dipyridamole/Magnesium To Improve Sickle Cell Hydration
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the benefits as well as side effects of giving
drugs called dipyridamole and magnesium to patients with sickle cell anemia (SCA).